Dopaminergic vasodilation in the choroidal circulation by D1/D5 receptor activation

被引:34
|
作者
Reitsamer, HA
Zawinka, C
Branka, M
机构
[1] Univ Vienna, Sch Med, Dept Physiol, A-1090 Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Clin Pharmacol, A-1090 Vienna, Austria
关键词
D O I
10.1167/iovs.03-0997
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To test whether exogenous dopamine can cause choroidal vasodilation and to identify the mediating receptors in anesthetized rabbits. METHODS. Mean arterial pressure (MAP), intraocular pressure (IOP), and orbital venous pressure (OVP) were measured by direct cannulation of the central ear artery, the vitreous, and the orbital venous sinus, respectively. Laser Doppler flowmetry was used to measure choroidal blood flow (ChorBF) while MAP was manipulated mechanically with occluders on the aorta and vena cava, thus changing perfusion pressure (PP) over a wide range. In the first group of animals (n = 11) pressure-flow (PF) relationships were performed at control and in response to 40 mug/kg per minute intravenous (IV) dopamine (D40) and D40+SCH-23390 (0.5 mg/kg, bolus injection IV). In the second group of animals (n = 6), PF relationships were recorded at control and during infusion of SKF38393 (80 mug/kg per minute). RESULTS. D40 lowered IOP and caused an upward shift in the choroidal PF relationship, which was blocked by the D1/D5 antagonist SCH-23390 suggesting the involvement of the dopamine D1/D5 receptors. Stimulation of the D1/D5 receptors by infusion of the selective agonist SKF-38393 also lowered IOP and caused an upward shift in the PF relationship. Dopamine and SKF-38393 tended to decrease OVP, but the effect was not significant. CONCLUSIONS. Dopamine can cause choroidal vasodilation in anesthetized rabbits. Because SCH-23390 was able to block the response and SKF-38393 caused a similar vasodilation, we conclude that the vasodilation is caused by a D1/D5-receptor-mediated mechanism.
引用
收藏
页码:900 / 905
页数:6
相关论文
共 50 条
  • [1] Dopaminergic stimulation increases heterologous D1 and D5 dopamine receptor interaction
    Gildea, John J.
    Israel, Jonathan A.
    Jose, Pedro A.
    Felder, Robin A.
    HYPERTENSION, 2007, 50 (04) : E143 - E144
  • [2] Attenuated responses to a D1/D5 agonist in dopamine D5 receptor knockout mice
    Holmes, A
    Holton, TR
    Liu, Z
    Dreiling, J
    Gleason, TC
    Sibley, DR
    Crawley, JN
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 172 - 172
  • [3] D1/D5 Modulation of Synaptic NMDA Receptor Currents
    Varela, Juan A.
    Hirsch, Silke J.
    Chapman, David
    Leverich, Leah S.
    Greene, Robert W.
    JOURNAL OF NEUROSCIENCE, 2009, 29 (10): : 3109 - 3119
  • [4] FUNCTION OF THE FIRST INTRACELLULAR LOOP FOR HUMAN D1 AND D5 DOPAMINERGIC RECEPTORS
    Zhang, Boyang
    Tiberi, Mario
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2013, 33 (03) : 205 - 205
  • [5] Function of the first intracellular loop for human D1 and D5 dopaminergic receptors
    Zhang, Boyang
    Tiberi, Mario
    FASEB JOURNAL, 2013, 27
  • [6] Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor
    Gildea, John J.
    Wang, Xiaoli
    Jose, Pedro A.
    Felder, Robin A.
    HYPERTENSION, 2008, 51 (02) : 360 - 366
  • [7] Biosynthesis of the dopamine D1, D4, and D5 receptor polypeptides
    Bergson, C
    Lidow, M
    GoldmanRakic, P
    Levenson, R
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 453 - 453
  • [8] Dopamine D1/D5 receptor antagonists with improved pharmacokinetics:: Design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists
    Wu, WL
    Burnett, DA
    Spring, R
    Greenlee, WJ
    Smith, M
    Favreau, L
    Fawzi, A
    Zhang, HT
    Lachowicz, JE
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) : 680 - 693
  • [9] Electrified fluctuations in D1⊥D3 and D1⊥D5 systems
    Douari, Jamila
    NUCLEAR PHYSICS B, 2009, 808 (03) : 592 - 612
  • [10] Adsorption of a quantum in D1/D5 system
    Park, IY
    PHYSICS LETTERS B, 2004, 591 (3-4) : 325 - 333